Search

everythinglearnresearchcommunity

for

Search:↓

Regenerative medicine shows promise for improving hair and skin but needs more research for standard use.

Recent findings suggest that genetic factors, immune system issues, and skin cell defects might contribute to the development of hidradenitis suppurativa.

LC-OCT is an effective new method for diagnosing classic lichen planopilaris.

The Thai version of the Family Dermatology Life Quality Index is a reliable and valid tool for assessing the quality of life of patients' families.

Using a special shampoo and scalp tonic together can greatly reduce severe dandruff and its causes.

Wild strawberry waste extract can be a sustainable cosmetic ingredient for treating acne and hair loss.

People with seborrheic dermatitis often have lower vitamin D levels.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Hidradenitis Suppurativa has genetic links, with certain gene mutations more common in patients and a third of cases having a family history.

Mesenchymal Stem/Stromal Cells (MSCs) help in wound healing and tissue regeneration, but can also contribute to tumor growth. They show promise in treating chronic wounds and certain burns, but their full healing mechanisms and potential challenges need further exploration.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

New hair follicle-targeting treatments show promise for hair disorders but need more research on safety and effectiveness.

Keratin protein production in cells is controlled by a complex system that changes with cell type, health, and conditions like injury or cancer.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

Dandruff might be caused by changes in how hair follicles naturally release oils and an immune response to this imbalance.

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Hair loss from conditions like LPP and FFA can potentially be reversed with the right treatment.

The enzymes Tet1, Tet2, and Tet3 are important for the development of hair follicles and determining hair shape by controlling hair keratin genes.

People with androgenetic alopecia may have a higher risk of heart problems compared to those with alopecia areata or healthy individuals.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

SM04554 may increase hair growth as a topical treatment for androgenetic alopecia.

Trichoscopy helps tell apart scalp lesions in pemphigus vulgaris and pemphigus foliaceus and is useful for choosing biopsy locations.

Patients with psoriasis and cutaneous-oral lichen planus have higher blood homocysteine levels than healthy people.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Topical latanoprost and bimatoprost eye solutions don't help eyelash growth in people with alopecia areata.